Research in Motion: Golam Mohi, PhD
9/2/2025
We are interested in understanding how different mutations associated with blood cancer contribute to the disease. Our ultimate goal is to find new therapeutic targets and develop novel therapies for…
UVA-Linked Commonwealth BioAccelerator Nets Millions More in Funding
8/25/2025
State leaders announced last week that they have allocated another $7.5 million to fund the Commonwealth BioAccelerator at the University of Virginia’s North Fork Discovery Park. The University will match…
BIMS Summer Research Internship Program Hosts 27 Undergraduates
8/25/2025
UVA's Summer Research Internship Program (SRIP) hosted 27 undergraduate students for a summer research experience in biomedical sciences that concluded on August 1. Selected students from colleges and universities from…
iTHRIV Scholars Program Celebrates Nine Years of Faculty Career Development
8/25/2025
The Integrated Translational Health Research Institute of Virginia (iTHRIV) Scholars Program recently celebrated the start of its ninth year. The all-virtual mentored career development program supports competitively appointed faculty from…
How AI Will Transform Mental Health Support for Breast Cancer Patients
8/25/2025
From virtual counselors that can hear depression creeping into a person’s voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients…
8/25/2025
The University of Virginia has been awarded a new $3.4 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to tackle one of the most pressing…
Research in Motion: Alison Criss, PhD
8/25/2025
Our research uncovers how the foot soldiers of our immune system, called neutrophils, recognize and respond to microbes, and how pathogens, including the bacterium that causes gonorrhea, manages to subvert…
UVA Researchers Awarded $13 Million to Lead National Study to Battle Leukemia
8/25/2025
UVA Comprehensive Cancer Center Director Thomas P. Loughran Jr., MD, and Professors of Medicine/Hematology and Oncology Charles Chalfant, PhD, and David Feith, PhD, have been awarded a new five-year, $13…
